Abstract
Urea transporters (UTs) are a kind of transmembrane protein that specifically permeate urea, and play an important role in the mechanism of urine concentration. Selective knockout of UT can concentrate urea without affecting water and electrolytes, resulting in selective diuresis, which is a promising new diuretic target. Most of the currently reported UT inhibitors are obtained from small molecular libraries screened. We subjected the methanolic extract of celery seed to silica gel column chromatography analysis, and screened the column chromatographic fractions of celery seed for UT-B inhibitory activity using the reported erythrocyte lysis model. The UT-B inhibitory activity was also screened for the fractions of celery seed separated by column chromatography, using the reported erythrocyte lysis model. The chemical composition of the active site was identified using UPLC-TOF-MS, and the active compounds were selected in combination with molecular docking and ADMET prediction. Screening of the extracted parts of celery seed, using an erythrocyte lysis model, yielded nine small molecules with good inhibitory activity, namely esters, phenols, and organic acids. This experiment shows that compounds with UT-B inhibitory effects can be found in ethnic medicinal materials, which not only provides new ideas for the discovery of UT-B inhibitors, but also contributes to the development of ethnic medicines.
Supplementary Materials
Conference poster. The file is available at https://www.mdpi.com/article/10.3390/ECMC2022-13278/s1.
Author Contributions
Conceptualization, X.P. and X.Y.; methodology, X.P. and X.Y.; experiment, W.W., and N.X., software, G.C.; validation, X.P.; formal analysis, W.W.; investigation, W.W.; resources, W.W.; data curation, G.C.; writing—original draft preparation, G.C.; writing—review and editing, X.P.; supervision, X.P. and X.Y. All authors have read and agreed to the published version of the manuscript.
Funding
This study was supported by National Natural Science Foundation of China (82160651); The Open Project of Stake Key Laboratory of Natural and Biomimetic Drugs, Peking University (K202103); The Open Project of Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education (XPRU202004); Youth Innovative Talent Cultivation Projects of Shihezi University (CXPY202005) and The Open Sharing Fund for the Large-scale Instruments and Equipments of Shihezi University.
Institutional Review Board Statement
The animal study protocol was approved by the Ethics Committee of the First Affiliated Hospital, School of Medicine, Shihezi University (protocol code A2022-209-01).
Informed Consent Statement
Not applicable.
Data Availability Statement
The data presented in this study are available in the article.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).